| abstract |
The present disclosure provides a nucleic acid fragment, a pharmaceutical composition, and a therapeutic process for treating a subject having chronic obstructive pulmonary disease (COPD). Especially, the nucleic acid fragment, the pharmaceutical composition, and the therapeutic process are therapeutic-efficient for treating pulmonary fibrosis and emphysema of the subject, as demonstrated in this disclosure. |